April Stevens
Medical · Richmond, KYNPI 1891059895
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 350 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 42 manufacturers, the largest accounting for just 11.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,610 and has fallen 62.8% since, to $598 in 2025. Among medical clinicians in KY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 350 payments — averaging $16.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$649
- Amgen$562
- GSK$478
- AbbVie$460
- Novartis$450
- Vanda Pharmaceuticals Inc.$392
- plus $3K from 36 others
What the payments were for
- Food & beverage$5,737100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$5,737 in reported general payments places this provider in the 90th percentile of 222 medical providers in Kentucky.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 102 | $125,091 |
| OzempicSemaglutide | 47 | $61,137 |
| Tresiba Flextouch U-200Insulin Degludec | 60 | $52,662 |
| TrulicityDulaglutide | 22 | $43,345 |
| EliquisApixaban | 34 | $34,243 |
| RybelsusSemaglutide | 19 | $31,122 |
| Repatha SureclickEvolocumab | 36 | $29,700 |
| JardianceEmpagliflozin | 34 | $25,066 |
| VraylarCariprazine Hcl | 15 | $20,586 |
| EntrestoSacubitril/Valsartan | 21 | $17,331 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 12 | $9,681 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 15 | $9,354 |
| Emgality PenGalcanezumab-Gnlm | 11 | $7,642 |
| MyrbetriqMirabegron | 15 | $7,349 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 12 | $7,073 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $649 | $168,436124 claims |
| Novo NordiskOzempic, Rybelsus | $303 | $92,25966 claims |
| PfizerEliquis | $151 | $34,24334 claims |
| Boehringer IngelheimJardiance, Stiolto Respimat | $102 | $32,13946 claims |
| AbbVieVraylar, Synthroid | $460 | $23,20952 claims |
| NovartisEntresto | $450 | $17,33121 claims |
| GSKTrelegy Ellipta | $478 | $9,68112 claims |
| AstraZenecaBreztri Aerosphere | $102 | $9,35415 claims |
| Astellas Pharma US IncMyrbetriq | $54 | $7,34915 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 222 medical providers in Kentucky.
Other medical in Richmond
- Mikal BaileyPaducah$84K
- Kyle HeraldBowling Green$65K
- Chasity HesterLexington$16K
- Alexandra HuettLouisville$13K
- Danny ThackerFrankfort$11K
- Jessica FrizzellPaducah$10K
- Terry SmithHazard$10K
- Ashley HenegarGeorgetown$10K
- Rachel CrowleyPaducah$8K
- Allison ScottLexington$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.